Zura Bio Limited (ZURA)

Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $454.48 million. The enterprise value is $228.88 million.

Market Cap	454.48M
Enterprise Value	228.88M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 94.88 million shares outstanding. The number of shares has increased by 14.31% in one year.

Current Share Class	94.88M
Shares Outstanding	94.88M
Shares Change (YoY)	+14.31%
Shares Change (QoQ)	+18.36%
Owned by Insiders (%)	11.64%
Owned by Institutions (%)	36.76%
Float	54.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.10
P/TBV Ratio	2.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.33

Current Ratio	19.33
Quick Ratio	19.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.96% and return on invested capital (ROIC) is -27.66%.

Return on Equity (ROE)	-40.96%
Return on Assets (ROA)	-25.39%
Return on Invested Capital (ROIC)	-27.66%
Return on Capital Employed (ROCE)	-37.57%
Weighted Average Cost of Capital (WACC)	4.74%
Revenue Per Employee	n/a
Profits Per Employee	-$2.65M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +289.43% in the last 52 weeks. The beta is 0.09, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+289.43%
50-Day Moving Average	5.85
200-Day Moving Average	4.31
Relative Strength Index (RSI)	37.58
Average Volume (20 Days)	675,207

Short Selling Information

The latest short interest is 6.15 million, so 6.49% of the outstanding shares have been sold short.

Short Interest	6.15M
Short Previous Month	5.75M
Short % of Shares Out	6.49%
Short % of Float	11.24%
Short Ratio (days to cover)	9.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-81.49M
Pretax Income	-75.43M
Net Income	-106.13M
EBITDA	-81.44M
EBIT	-81.49M
Earnings Per Share (EPS)	-$1.07

Balance Sheet

The company has $225.59 million in cash and n/a in debt, with a net cash position of $225.59 million or $2.38 per share.

Cash & Cash Equivalents	225.59M
Total Debt	n/a
Net Cash	225.59M
Net Cash Per Share	$2.38
Equity (Book Value)	216.90M
Book Value Per Share	2.29
Working Capital	215.26M

Cash Flow

In the last 12 months, operating cash flow was -$72.68 million and capital expenditures -$77,000, giving a free cash flow of -$72.75 million.

Operating Cash Flow	-72.68M
Capital Expenditures	-77,000
Depreciation & Amortization	56,000
Net Borrowing	n/a
Free Cash Flow	-72.75M
FCF Per Share	-$0.77

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.31%
Shareholder Yield	-14.31%
Earnings Yield	-23.35%
FCF Yield	-16.01%

Analyst Forecast

The average price target for Zura Bio is $13.00, which is 171.40% higher than the current price. The consensus rating is "Buy".

Price Target	$13.00
Price Target Difference	171.40%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2